Lukas Helbig

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Treatment choice for localized prostate cancer (PCa) is a controversial issue, and mortality risk is probably the most decisive factor in this regard. The study aimed to compare prostate-cancer-specific mortality risk estimates for different treatment options assigned by patients managed with active surveillance (AS), radical prostatectomy (RP) and patients(More)
  • 1